World's Best Scientists 2026 revealed!
VIEW LIST
Kim Papp

D-Index & Metrics

Medicine

D-Index
112
Citations
56178
World Ranking
5088
National Ranking
200

Kim Papp publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kim Papp sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 619 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kim Papp D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kim Papp sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 112 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kim Papp is affiliated with Probity Medical Research in Canada and has contributed extensively to the fields of medicine, immunology, and dermatology. Their research productivity spans multiple areas such as immunology, rheumatology, pediatrics, and allergy, with a focus on skin diseases and autoimmune conditions.

The primary research domains include:

  • Medicine
  • Immunology and Microbiology

Within these domains, subfields of study highlight:

  • Immunology
  • Dermatology
  • Rheumatology
  • Immunology and Allergy
  • Pediatrics, Perinatology and Child Health

Papp's research topics cover a broad spectrum of dermatological and immunological issues, with an emphasis on clinical treatment and pharmaceutical research. The main subjects of their work include:

  • Psoriasis: Treatment and Pathogenesis
  • Dermatology and Skin Diseases
  • Pharmaceutical Studies and Practices
  • Autoimmune Bullous Skin Diseases
  • Health Systems, Economic Evaluations, Quality of Life
  • Asthma and Respiratory Diseases
  • Allergic Rhinitis and Sensitization

Their frequent collaborators indicate active engagement in multidisciplinary research. Notable co-authors are:

  • Melinda Gooderham
  • Andrew Blauvelt
  • Mark Lebwohl
  • Leon Kircik
  • Linda Stein Gold

Papp has published in a number of dermatology and medical journals. The most recurrent venues for their work include:

  • Journal of the American Academy of Dermatology
  • SKIN The Journal of Cutaneous Medicine
  • Dermatology and Therapy
  • British Journal of Dermatology
  • Journal of the European Academy of Dermatology and Venereology

Recent publications by Kim Papp illustrate the focus on clinical trials and therapeutic interventions for skin diseases. Selected papers include:

  • "Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials," 2021, The Lancet
  • "Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial," 2022, Journal of the American Academy of Dermatology
  • "Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial," 2021, The Lancet
  • "Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies," 2021, Journal of the American Academy of Dermatology
  • "Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program for Evaluation of TYK2 inhibitor psoriasis second trial," 2022, Journal of the American Academy of Dermatology

Best Publications

  • Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

    Craig L Leonardi;Alexa B Kimball;Kim A Papp;Newman Yeilding

  • Secukinumab in plaque psoriasis--results of two phase 3 trials.

    Richard G. Langley;Boni E. Elewski;Mark Lebwohl;Kristian Reich

  • Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

    Andrew Blauvelt;Marjolein de Bruin-Weller;Melinda Gooderham;Jennifer C. Cather

  • Infliximab induction and maintenance therapy for moderate-to-severe psoriasis : a phase III, multicentre, double-blind trial

    Kristian Reich;Frank O Nestle;Kim Papp;Jean-Paul Ortonne

  • Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

    Stephen Tyring;Alice Gottlieb;Kim Papp;Ken Gordon

  • Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

    Kim A Papp;Craig Leonardi;Alan Menter;Jean-Paul Ortonne

  • Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

    Alan Menter;Stephen K. Tyring;Kenneth Gordon;Alexa B. Kimball

  • Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

    Mark Lebwohl;Bruce Strober;Alan Menter;Kenneth Gordon

  • Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial

    Andrew Blauvelt;Kim A. Papp;Christopher E.M. Griffiths;Bruce Randazzo;Bruce Randazzo

  • A global phase III randomized controlled trial of etanercept in psoriasis : safety, efficacy, and effect of dose reduction

    Kim A. Papp;S. Tyring;M. Lahfa;J. Prinz

  • Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

    Christopher E M Griffiths;Kristian Reich;Mark Lebwohl;Peter van de Kerkhof

  • Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).

    Jean-Hilaire Saurat;G. Stingl;L. Dubertret;K. Papp

  • Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

    Kenneth B Gordon;Jean-Frederic Colombel;Dana S Hardin

  • Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.

    Arthur Kavanaugh;Iain McInnes;Philip Mease;Gerald G. Krueger

  • Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.

    Alexa B Kimball;Martin M Okun;David A Williams;Alice B Gottlieb

  • Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.

    Diamant Thaçi;Eric L Simpson;Lisa A Beck;Thomas Bieber

  • Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)

    Kim Papp;Kristian Reich;Craig L. Leonardi;Leon Kircik

  • A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis

    Alan Menter;Steven R. Feldman;Gerald D. Weinstein;Kim Papp

  • Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)

    Michelle A. Lowes;Francesca Chamian;Maria Veronica Abello;Judilyn Fuentes-Duculan

  • Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

    Kenneth B Gordon;Bruce Strober;Mark Lebwohl;Matthias Augustin

Frequent Co-Authors

Richard G. Langley
Richard G. Langley Dalhousie University
Kenneth B. Gordon
Kenneth B. Gordon Medical College of Wisconsin
Mark Lebwohl
Mark Lebwohl Icahn School of Medicine at Mount Sinai
Andrew Blauvelt
Andrew Blauvelt Veterans Health Administration
Kristian Reich
Kristian Reich University of Göttingen
Alice B. Gottlieb
Alice B. Gottlieb Icahn School of Medicine at Mount Sinai
Craig L. Leonardi
Craig L. Leonardi Saint Louis University
Christopher E.M. Griffiths
Christopher E.M. Griffiths University of Manchester
Carle Paul
Carle Paul Federal University of Toulouse Midi-Pyrénées
Diamant Thaçi
Diamant Thaçi University of Lübeck

External Links

Personal website of Kim Papp

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in medicine but want alternative education pathways, many accredited online programs offer flexible options. For nurses seeking advancement, some rn to bsn online no clinicals programs eliminate the need for on-site clinicals, making it more convenient for working professionals to earn their degree.

Those aiming for leadership or advanced practice roles might consider pursuing graduate studies. There are now shortest online dnp program options, which allow qualified nurses to obtain a Doctor of Nursing Practice quickly. Some institutions even offer easiest dnp programs that emphasize practical coursework and manageable requirements, appealing to those balancing work and study.

For those looking to enter the healthcare field faster, fast track lpn programs online enable students to become Licensed Practical Nurses in a shorter period. These pathways support a diverse range of career goals—from bedside care to advanced practice—while taking advantage of flexible, accessible online learning.

Best Scientists Citing Kim Papp

Alice B. Gottlieb

Alice B. Gottlieb

Icahn School of Medicine at Mount Sinai

Publications: 185

Steven R. Feldman

Steven R. Feldman

Wake Forest University

Publications: 165

Mark Lebwohl

Mark Lebwohl

Icahn School of Medicine at Mount Sinai

Publications: 164

Philip J. Mease

Philip J. Mease

University of Washington

Publications: 126

James G. Krueger

James G. Krueger

Rockefeller University

Publications: 116

Emma Guttman-Yassky

Emma Guttman-Yassky

Icahn School of Medicine at Mount Sinai

Publications: 107

Christopher E.M. Griffiths

Christopher E.M. Griffiths

University of Manchester

Publications: 103

Alan Menter

Alan Menter

Texas A&M University

Publications: 96

Carle Paul

Carle Paul

Federal University of Toulouse Midi-Pyrénées

Publications: 88

Kenneth B. Gordon

Kenneth B. Gordon

Medical College of Wisconsin

Publications: 88

Ulrich Mrowietz

Ulrich Mrowietz

Kiel University

Publications: 85

Matthias Augustin

Matthias Augustin

Universität Hamburg

Publications: 81

Giampiero Girolomoni

Giampiero Girolomoni

University of Verona

Publications: 78

Richard G. Langley

Richard G. Langley

Dalhousie University

Publications: 77

Dafna D. Gladman

Dafna D. Gladman

Toronto Western Hospital

Publications: 72

Iain B. McInnes

Iain B. McInnes

University of Glasgow

Publications: 69

Trending Scientists

Jibo Wei

Jibo Wei

National University of Defense Technology

Mary Crawford

Mary Crawford

University of Connecticut

Anja S. Göritz

Anja S. Göritz

University of Freiburg

Claudia Mohr

Claudia Mohr

ETH Zurich

Wolfgang Kneifel

Wolfgang Kneifel

BOKU University

Chhinder P. Sodhi

Chhinder P. Sodhi

Johns Hopkins University

Enru Liu

Enru Liu

ExxonMobil (United States)

Heinrich Bahlburg

Heinrich Bahlburg

University of Münster

Jian-Hua Luo

Jian-Hua Luo

University of Pittsburgh

Baltasar Fernández-Manjón

Baltasar Fernández-Manjón

Complutense University of Madrid

Haralambos Mouratidis

Haralambos Mouratidis

University of Essex

Michael Sharpe

Michael Sharpe

University of Oxford

Daniel J. Hicklin

Daniel J. Hicklin

Eli Lilly (United States)

Mariano Lastra

Mariano Lastra

Universidade de Vigo

Sylvain Dubey

Sylvain Dubey

University of Lausanne

Emily S. Darling

Emily S. Darling

Wildlife Conservation Society

Related Medicine Rankings & Guides

2026 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in Mississippi – Accredited Schools Online & Campus
2026 How Much Do Medical Assistant Programs & Certifications Cost?

2026 How Much Do Medical Assistant Programs & Certifications Cost?
2026 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs

2026 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs
2026 Best Nurse Practitioner Programs in Ohio – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in Ohio – Accredited Schools Online & Campus
2026 Best Occupational Therapy Programs

2026 Best Occupational Therapy Programs
2026 Best Online DNP Programs Without Clinicals

2026 Best Online DNP Programs Without Clinicals
2026 Fastest Doctor of Nursing Practice (DNP) Degree Programs

2026 Fastest Doctor of Nursing Practice (DNP) Degree Programs
2026 Most Affordable Online LVN Programs

2026 Most Affordable Online LVN Programs
2026 Most Affordable CNA to RN Online Bridge Programs

2026 Most Affordable CNA to RN Online Bridge Programs
August 2026 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs

August 2026 Fast Track LPN Programs Online - 6, 9, 10, 11, 12 Month Programs
2026 Best Online CAHME-Accredited MHA Programs

2026 Best Online CAHME-Accredited MHA Programs
2026 Best Online Nursing Degree Programs

2026 Best Online Nursing Degree Programs
2026 Best Online Master’s in Clinical Research Programs

2026 Best Online Master’s in Clinical Research Programs
2026 Fastest Online Pharmacy Technician Certificate Programs

2026 Fastest Online Pharmacy Technician Certificate Programs
2026 Fastest Online MSN in Nursing Education Programs

2026 Fastest Online MSN in Nursing Education Programs
2026 Easiest Nurse Practitioner Degree Programs

2026 Easiest Nurse Practitioner Degree Programs
2026 Most Affordable Master’s in Health Science Degrees

2026 Most Affordable Master’s in Health Science Degrees
2026 Best Nurse Practitioner Programs in New York – Accredited Schools Online & Campus

2026 Best Nurse Practitioner Programs in New York – Accredited Schools Online & Campus
2026 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus

2026 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus
2026 Healthcare Administration Degree Guide: Costs, Requirements & Job Opportunities

2026 Healthcare Administration Degree Guide: Costs, Requirements & Job Opportunities
2026 Most Affordable Online Direct Entry MSN Programs for Non-Nurses

2026 Most Affordable Online Direct Entry MSN Programs for Non-Nurses

Recently Published Articles

2026 Most Affordable Online Artificial Intelligence Degree Programs

2026 Most Affordable Online Artificial Intelligence Degree Programs
2026 Most Affordable Online Bachelor's in Mathematics Degree Programs

2026 Most Affordable Online Bachelor's in Mathematics Degree Programs
2026 Different Types of Public Health Master's Degrees: Specializations, Careers, and Salaries

2026 Different Types of Public Health Master's Degrees: Specializations, Careers, and Salaries
2026 Best Medical Assistant to RN Online Bridge Programs

2026 Best Medical Assistant to RN Online Bridge Programs
2026 Highest Level of Biomimicry Degree You Can Achieve: Academic Progression Explained

2026 Highest Level of Biomimicry Degree You Can Achieve: Academic Progression Explained
2026 Military-Friendly Online Religious and Christian Studies Bachelor's Degree Programs

2026 Military-Friendly Online Religious and Christian Studies Bachelor's Degree Programs
2026 LMFT Accreditation: Online COAMFTE-Accredited Programs to Consider

2026 LMFT Accreditation: Online COAMFTE-Accredited Programs to Consider
2026 Best Master’s in Dietetics Programs

2026 Best Master’s in Dietetics Programs
2026 Self-Paced Online Fashion Design Bachelor's Degree Programs

2026 Self-Paced Online Fashion Design Bachelor's Degree Programs
2026 Most Affordable Online MSW Programs

2026 Most Affordable Online MSW Programs
2026 Fastest Online Environmental Science Bachelor's Degree Programs You Can Finish in 3 Years or Less

2026 Fastest Online Environmental Science Bachelor's Degree Programs You Can Finish in 3 Years or Less
2026 Fastest Online Master’s Programs in Educational Leadership

2026 Fastest Online Master’s Programs in Educational Leadership
2026 CMA vs RMA vs CCMA: Explaining The Difference

2026 CMA vs RMA vs CCMA: Explaining The Difference
2026 Most Affordable Online Master’s in Counseling Degree Programs

2026 Most Affordable Online Master’s in Counseling Degree Programs
2026 What Careers Can You Pursue With an Animal Science Degree? Salary Potential, Job Outlook, and Next Steps

2026 What Careers Can You Pursue With an Animal Science Degree? Salary Potential, Job Outlook, and Next Steps
2026 How to Become a Nurse Practitioner without a BSN Degree: Education, Salary, and Job Outlook

2026 How to Become a Nurse Practitioner without a BSN Degree: Education, Salary, and Job Outlook
2026 AI, Automation, and the Future of Forensic Science Degree Careers

2026 AI, Automation, and the Future of Forensic Science Degree Careers
2026 Sports Analytics Internship Requirements: Hours, Placements, and Supervision

2026 Sports Analytics Internship Requirements: Hours, Placements, and Supervision
2026 Radiology Technician vs. Respiratory Therapist Degree: Explaining the Difference

2026 Radiology Technician vs. Respiratory Therapist Degree: Explaining the Difference
2026 Best Online ABET-Accredited Engineering Degree Programs

2026 Best Online ABET-Accredited Engineering Degree Programs
2026 How to Become a Licensed Pharmacist in California

2026 How to Become a Licensed Pharmacist in California